Neobe Therapeutics
PrivateLast Round
Seed
Feb 29, 2024
Total Funding Raised
$2.96M
Company Overview
Neobe Therapeutics is a biotechnology company developing a synthetic biology platform to engineer programmable bacteria that remodel the microenvironment of solid tumors to improve immunotherapy efficacy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neobe Therapeutics Comparables
Compare Neobe Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prokarium | 85% | |
| Baccine Ltd. | 81% | |
| Ernest Pharmaceuticals | 79% |
Neobe Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 29, 2024 | ||||
| Pre Seed | Nov 22, 2022 |
Neobe Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deep Science Ventures | Seed |
| Pioneer Group | Seed |
| Innovate UK | Seed, Pre Seed |
| 2048 Ventures | Seed |
| Cancer Research Horizons | Seed |
| Discovery Park Ventures | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2026
Monthly visitors increased 51% MoM.
- Sep 16, 2025
Received the Pathfinder award at the Cambridge Business Weekly Awards.
Neobe Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neobe Therapeutics's valuation, stock price, and market status.
Is Neobe Therapeutics a public or private company?
Neobe Therapeutics is a private company.
What is the current stock price of Neobe Therapeutics?
Neobe Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Neobe Therapeutics worth (valuation)?
Valuation information for Neobe Therapeutics is not publicly available.
Can I buy Neobe Therapeutics stock?
Neobe Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Neobe Therapeutics's last funding round?
Neobe Therapeutics's most recent funding round was Seed on February 29, 2024.
Who are the main investors in Neobe Therapeutics?
Key investors in Neobe Therapeutics include Pioneer Group, Discovery Park Ventures.
Will Neobe Therapeutics IPO soon?
No public IPO plans have been announced for Neobe Therapeutics.
How can I track Neobe Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neobe Therapeutics's secondary market activity and sign up for updates.